Select Publications
Journal articles
2007, 'The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women', Osteoporosis International, 18, pp. 1033 - 1046, http://dx.doi.org/10.1007/s00198-007-0343-y
,2007, 'Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194))', Journal of Bone and Mineral Research, 22, pp. 774, http://dx.doi.org/10.1359/jbmr.050304e
,2007, 'Predictive value of BMD for hip and other fractures (vol 20, pg 1185, 2005)', JOURNAL OF BONE AND MINERAL RESEARCH, 22, pp. 774 - 774, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245934000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Osteoporosis update 1/2007', Osteologie, 16, pp. 53 - 59, http://dx.doi.org/10.1024/1019-1291.16.1.53
,2007, 'Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts', Journal of Clinical Endocrinology and Metabolism, 92, pp. 3599 - 3603
,2007, 'Bone loss and hip fracture: A revisit with time-varying effects', Bone, 40, pp. S140 - S140
,2007, 'Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women', Journal of Bone and Mineral Research, 22, pp. 1147 - 1154
,2007, 'Bone mineral density and hip fracture: A revisit with time-varying effects', Journal of Bone and Mineral Research, 22, pp. S22 - S23
,2007, 'Bone turnover in elderly men: relationships to change in bone mineral density', BMC Musculoskeletal Disorders, 8
,2007, 'Clinical risk factors enhance the performance of BMD in the prediction of fractures', Calcified Tissue International, 80, pp. S29 - S29
,2007, 'Development of a clinical nomogram for individualizing 5-year and 10-year risks of fracture', Bone, 40, pp. S148 - S149
,2007, 'Development of a nomogram for individualizing hip fracture risk in men and women', Osteoporosis International, 18, pp. 1109 - 1117
,2007, 'Discordance of longitudinal changes in bone density between densitometers', Bone, 41, pp. 690 - 697, http://dx.doi.org/10.1016/j.bone.2007.07.002
,2007, 'Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation', Bone, 41, pp. 87 - 96
,2007, 'Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression', The Journal of Biological Chemistry, 282, pp. 19082 - 19091
,2007, 'Intermittent intravenous (i.v.) ibandronate injections are more effective than an established daily oral regimen: DIVA 2-year results', Osteoporosis International, 18, pp. S127 - S127
,2007, 'Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis', The Journal of Biological Chemistry, 282, pp. 19092 - 19102, http://dx.doi.org/10.1074/jbc.M700644200
,2007, 'On the association between statin and fracture: A Bayesian consideration', Bone, 40, pp. 813 - 820
,2007, 'Residual lifetime risk of fractures in women and men', Journal of Bone and Mineral Research, 22, pp. 781 - 788
,2007, 'Risk factors for fracture in nonosteoporotic men and women', Journal of Clinical Endocrinology and Metabolism, 92, pp. 955 - 962
,2007, 'Risk of subsequent fracture after low-trauma fracture in men and women', JAMA - Journal of the American Medical Association, 297, pp. 387 - 394
,2007, 'Risk of subsequent fracture depends on bone mineral density and fracture type: A 15-year prospective study', Journal of Bone and Mineral Research, 22, pp. S14 - S14
,2007, 'Successful direct intervention for osteoporosis in patients with minimal trauma fractures', Osteoporosis International, 18, pp. 1633 - 1639
,2006, 'Erratum: Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (Journal of Biological Chemistry (2006) 281, (23436-23444))', Journal of Biological Chemistry, 281, pp. 38966
,2006, 'β3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES)', BMC Medical Genetics, 7, http://dx.doi.org/10.1186/1471-2350-7-57
,2006, 'Gideon Rodan 1934–2006', Journal of Bone and Mineral Research, 21, pp. 979 - 983, http://dx.doi.org/10.1359/jbmr.060700
,2006, 'Biomedical, academic, and industry interaction', Journal of Bone and Mineral Research, 21, pp. 353, http://dx.doi.org/10.1359/JBMR.060113
,2006, 'Ethics in publications', Journal of Bone and Mineral Research, 21, pp. 1 - 3, http://dx.doi.org/10.1359/JBMR.051010
,2006, 'A comparison of bone mineral measurements for fracture prediction: A meta-analysis', Osteoporosis International, 17, pp. S162 - S162
,2006, 'A randomised study of two different information-based interventions on the management of osteoporsis in minimal and moderate trauma fractures', Osteoporosis International, 17, pp. 1309 - 1317
,2006, 'Anti-hip fracture efficacy of bisphosphonates: A Bayesian analysis of clinical trials', Journal of Bone and Mineral Research, 21, pp. 340 - 349
,2006, 'beta 3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study ( DOES)', BMC Medical Genetics, 7
,2006, 'Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation', Bone, 38, pp. S6 - S6
,2006, 'Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice', The Journal of Biological Chemistry, 281, pp. 23436 - 23444, http://dx.doi.org/10.1074/jbc.M604839200
,2006, 'Deletion of hypothalamic neuropeptide Y2-receptors in adult mice protects against continued ovariectomy-induced bone loss', Bone, 38, pp. S6 - S6
,2006, 'Exploring factors influencing osteoporosis prevention and control: A qualitative study of Iranian men and women in Australia', Maturitas, 54, pp. 127 - 134
,2006, 'Gideon Rodan 1934-2006', Journal of Bone and Mineral Research, 21, pp. 983 - 983
,2006, 'Hypothalamic neuropeptide Y exerts a negative effect on cortical bone formation', Journal of Bone and Mineral Research, 21, pp. S65 - S65
,2006, 'Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 21, pp. 1600 - 1607
,2006, 'Incremental prognostic values of risk factors-based model for the prediction of fracture', Osteoporosis International, 17, pp. S149 - S149
,2006, 'Indirect comparison of anti-vertebral fracture efficacy among available therapies: A bayesian analysis', Osteoporosis International, 17, pp. S218 - S218
,2006, 'Intermittent intravenous ibandronate injections are an effective treatment option in postmenopausal osteoporosis: 2-year results from diva', Osteoporosis International, 17, pp. S212 - S212
,2006, 'Osteonecrosis of the jaw: More research needed', Journal of Bone and Mineral Research, 21, pp. 1503 - 1505
,2006, 'Pharmacogenomics of osteoporosis: opportunities and challenges', Journal of Musculoskeletal and Neuronal Interactions, 6, pp. 62 - 72
,2006, 'Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis', Osteoporosis International, 17, pp. S131 - S131
,2006, 'Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study', International Journal of Clinical Practice, 60, pp. 1013 - 1019
,2006, 'Serum testosterone is associated with subsequent fracture risk over 5 years in elderly men', Journal of Bone and Mineral Research, 21, pp. S6 - S7
,2006, 'The use of multiple sites for the diagnosis of osteoporosis', Osteoporosis International, 17, pp. 527 - 534
,2006, 'Vitamin D action and regulation of bone remodeling: Suppression of osteoclastogenesis by the mature osteoblast', Journal of Bone and Mineral Research, 21, pp. 1618 - 1626
,2005, 'The third phase', Journal of Bone and Mineral Research, 20, pp. 3 - 4
,